ArticleMolecular medicine (Cambridge, Mass.)2012

Interleukin-33 ameliorates experimental colitis through promoting Th2/Foxp3⁺ regulatory T-cell responses in mice.

Lihua Duan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.